Jushi Holdings (JUSHF) Total Liabilities (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Total Liabilities of $571.6 million for Q2 2026, up 12.04% year-over-year from $510.2 million in Q2 2025, and little changed quarter-over-quarter from $569.9 million in Q1 2026.
Jushi Holdings (JUSHF) Total Liabilities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Total Liabilities for 6 consecutive years, with $571.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities rose 12.04% year-over-year to $571.6 million; the TTM figure through Jun 2026 stood at $571.6 million (up 12.04% YoY), while the FY2025 annual figure was $537.7 million, up 9.61% from the prior year.
- Total Liabilities steadied at $571.6 million in Q2 2026 per JUSHF's latest filing, from $569.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $571.6 million in Q2 2026 and bottomed at $466.4 million in Q1 2022.
- Historically, Total Liabilities has averaged $499.4 million across 5 years, with a median of $485.5 million in 2022.
- Annual changes were most pronounced in 2023 — Total Liabilities retreated 2.6% — and 2026, when it rose 14.1%.
- Jushi Holdings' Total Liabilities stood at $483.4 million in 2022, then dropped by 2.57% to $471.0 million in 2023, then rose by 4.15% to $490.6 million in 2024, then rose by 9.61% to $537.7 million in 2025, then rose by 6.31% to $571.6 million in 2026.
- Business Quant data shows JUSHF's Total Liabilities at $571.6 million in Q2 2026, $569.9 million in Q1 2026, and $537.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 571.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 571.61 Mn |
| Mar 31, 2026 | 569.93 Mn |
| Dec 31, 2025 | 537.69 Mn |
| Sep 30, 2025 | 533.17 Mn |
| Jun 30, 2025 | 510.21 Mn |
| Mar 31, 2025 | 499.50 Mn |
| Dec 31, 2024 | 490.56 Mn |
| Sep 30, 2024 | 481.01 Mn |
| Jun 30, 2024 | 479.02 Mn |
| Mar 31, 2024 | 481.43 Mn |
| Dec 31, 2023 | 471.01 Mn |
| Sep 30, 2023 | 480.84 Mn |
| Jun 30, 2023 | 474.01 Mn |
| Mar 31, 2023 | 484.27 Mn |
| Dec 31, 2022 | 483.45 Mn |
| Sep 30, 2022 | 487.95 Mn |
| Jun 30, 2022 | 486.67 Mn |
| Mar 31, 2022 | 466.40 Mn |
| Dec 31, 2021 | 471.07 Mn |